Literature DB >> 35358103

Epidemiology and Outcomes of Multiple Organ Dysfunction Syndrome following Pediatric Trauma.

Elizabeth Y Killien, Jana M Zahlan1, Hetal Lad1, R Scott Watson, Monica S Vavilala, Roel L N Huijsmans, Frederick P Rivara.   

Abstract

BACKGROUND: Existing studies have found a low prevalence of multiple organ dysfunction syndrome (MODS) in pediatric trauma patients, typically applying adult criteria to single-center pediatric cohorts. We used pediatric criteria to determine the prevalence, risk factors, and outcomes of MODS among critically injured children in a national PICU database.
METHODS: We conducted a retrospective cohort study of PICU patients 1 month to 17 years with traumatic injury in the Virtual Pediatric Systems, LLC (VPS) database from 2009-2017. We used International Pediatric Sepsis Consensus Conference criteria to identify MODS on Day 1 of PICU admission and estimated the risk of mortality and poor functional outcome (Pediatric Overall/Cerebral Performance Category ≥3 with ≥1 point worsening from baseline) for MODS and for each type of organ dysfunction using generalized linear Poisson regression adjusted for age, comorbidities, injury type and mechanism, and post-operative status.
RESULTS: MODS was present on PICU Day 1 in 23.1% of 37,177 trauma patients (n = 8,592), with highest risk among patients with injuries associated with drowning, asphyxiation, and abuse. PICU mortality was 20.1% among patients with MODS vs. 0.5% among patients without MODS (adjusted RR 32.3, 95% CI 24.1-43.4). Mortality ranged from 1.5% for one dysfunctional organ system to 69.1% for ≥4 organ systems and was highest among patients with hematologic dysfunction (43.3%) or renal dysfunction (29.6%). Death or poor functional outcome occurred in 46.7% of MODS patients vs. 8.3% of patients without MODS (aRR 4.3, 95% CI 3.4-5.3).
CONCLUSIONS: MODS occurs more frequently following pediatric trauma than previously reported and is associated with high risk of morbidity and mortality. Based on existing literature using identical methodology, both the prevalence and mortality associated with MODS are higher among trauma patients than the general PICU population. Consideration of early organ dysfunction in addition to injury severity may aid prognostication following pediatric trauma. LEVEL OF EVIDENCE: III, prognostic/epidemiological study.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2022        PMID: 35358103      PMCID: PMC9525450          DOI: 10.1097/TA.0000000000003616

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.697


  38 in total

1.  The injured child is resistant to multiple organ failure: a different inflammatory response?

Authors:  Casey M Calkins; Denis D Bensard; Ernest E Moore; Robert C McIntyre; Christopher C Silliman; Walter Biffl; Alden H Harken; David A Partrick; Patrick J Offner
Journal:  J Trauma       Date:  2002-12

2.  Acute Respiratory Distress Syndrome Following Pediatric Trauma: Application of Pediatric Acute Lung Injury Consensus Conference Criteria.

Authors:  Elizabeth Y Killien; Roel L N Huijsmans; Iesha L Ticknor; Lincoln S Smith; Monica S Vavilala; Frederick P Rivara; R Scott Watson
Journal:  Crit Care Med       Date:  2020-01       Impact factor: 7.598

3.  Timing of mortality in pediatric trauma patients: A National Trauma Data Bank analysis.

Authors:  Cory McLaughlin; Jessica A Zagory; Michael Fenlon; Caron Park; Christianne J Lane; Daniella Meeker; Randall S Burd; Henri R Ford; Jeffrey S Upperman; Aaron R Jensen
Journal:  J Pediatr Surg       Date:  2017-10-08       Impact factor: 2.545

4.  Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study.

Authors:  Stéphane Leteurtre; Alain Martinot; Alain Duhamel; François Proulx; Bruno Grandbastien; Jacques Cotting; Ronald Gottesman; Ari Joffe; Jurg Pfenninger; Philippe Hubert; Jacques Lacroix; Francis Leclerc
Journal:  Lancet       Date:  2003-07-19       Impact factor: 79.321

5.  Paediatric index of mortality 3: an updated model for predicting mortality in pediatric intensive care*.

Authors:  Lahn Straney; Archie Clements; Roger C Parslow; Gale Pearson; Frank Shann; Jan Alexander; Anthony Slater
Journal:  Pediatr Crit Care Med       Date:  2013-09       Impact factor: 3.624

6.  Benchmarking the incidence of organ failure after injury at trauma centers and nontrauma centers in the United States.

Authors:  Matthew Benns; Brendan Carr; Michael J Kallan; Carrie A Sims
Journal:  J Trauma Acute Care Surg       Date:  2013-09       Impact factor: 3.313

7.  Non-neurologic organ dysfunction plays a major role in predicting outcomes in pediatric traumatic brain injury.

Authors:  Kamil Hanna; Mohammad Hamidi; Phillip Vartanyan; Marion Henry; Lourdes Castanon; Andrew Tang; Muhammad Zeeshan; Narong Kulvatunyou; Bellal Joseph
Journal:  J Pediatr Surg       Date:  2020-02-04       Impact factor: 2.545

8.  Signatures of inflammation and impending multiple organ dysfunction in the hyperacute phase of trauma: A prospective cohort study.

Authors:  Claudia P Cabrera; Joanna Manson; Joanna M Shepherd; Hew D Torrance; David Watson; M Paula Longhi; Mimoza Hoti; Minal B Patel; Michael O'Dwyer; Sussan Nourshargh; Daniel J Pennington; Michael R Barnes; Karim Brohi
Journal:  PLoS Med       Date:  2017-07-17       Impact factor: 11.069

9.  Interleukin-6 as inflammatory marker referring to multiple organ dysfunction syndrome in severely injured children.

Authors:  Hagen Andruszkow; Janika Fischer; Michael Sasse; Ulf Brunnemer; Julia Helga Karla Andruszkow; Axel Gänsslen; Frank Hildebrand; Michael Frink
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-03-03       Impact factor: 2.953

10.  Early changes within the lymphocyte population are associated with the development of multiple organ dysfunction syndrome in trauma patients.

Authors:  Joanna Manson; Elaine Cole; Henry D De'Ath; Paul Vulliamy; Ute Meier; Dan Pennington; Karim Brohi
Journal:  Crit Care       Date:  2016-06-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.